We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Six Months of British Cancer Research Organization’s Genetic Data Decoded in One Month by Smartphone Gamers

By LabMedica International staff writers
Posted on 23 Mar 2014
Print article
In just one month, “citizen scientists” have studied DNA data that would have taken a scientist six months to analyze by eye by playing a new smartphone game Play to Cure: Genes in Space.

If this amount of DNA was stretched out, it would stretch across 65 km. Amazingly, this is a distance equivalent to the length of more than 80 times the height of the Burj Khalifa in Dubai, the world’s tallest building.

These figures follow the February 2014 launch of the playing Cancer Research UK’s (London, UK) novel game, which global gamers of all ages can play on their smartphones and simultaneously analyze gene data. Cancer Research UK’s scientists must interpret huge amounts of information to find cancer-causing genetic defects in develop new targeted therapies for patients. However, the human eye is required to locate patterns in the data--computers are not effective enough. Furthermore, it would take scientists a long time to do this manually—sidetracking their time from other vital research.

But the collective power of the sheer numbers of gamers worldwide have sped this up, and will increase accuracy with many pairs of eyes examining each stretch of DNA. In just one month, there have been 1.5 million classifications through the game from players in almost every country in world. Furthermore, citizen scientists have collectively devoted more than 53,000 hours—six and a half years—playing the game and analyzed approximately 50% of the data from the first research project.

Hannah Keartland, Cancer Research UK's citizen science lead, said, “We’re astounded by this fantastic support from citizen scientists across the world which goes to show—you don’t need to wear a lab coat to be a hero. “It’s crucial we don’t stop here because the more people who play in their spare moments, the quicker we’ll make a difference. There never again needs to be such a thing as a boring queue. It’s still early days but we believe the collective force of global gamers could have a massive impact and speed up our life-saving research.”

Prof. Carlos Caldas, senior group leader at the Cancer Research UK Cambridge Institute, University of Cambridge (UK), said, “We’re incredibly grateful to everyone who is giving their spare moments to help us analyze genetic data. We’re working hard to develop better drugs, improve the diagnosis of cancer patients and understand why some treatments work and others won’t—to spare unpleasant side effects. Computers can’t analyze our research data with 100% accuracy—we need the human eye for greater precision. It can take us years to decode the huge amounts of data generated by research. But with everyone’s help the boost to our work could be enormous.”

The game is available to download now for free for anyone with an Android or Apple Smartphone.

Related Links:

Cancer Research UK 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.